900 related articles for article (PubMed ID: 28494063)
1. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
Gong Q; Janowski M; Luo M; Wei H; Chen B; Yang G; Liu L
JAMA Ophthalmol; 2017 Jun; 135(6):624-630. PubMed ID: 28494063
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis.
Ha A; Kim SJ; Shim SR; Kim YK; Jung JH
Ophthalmology; 2022 Mar; 129(3):322-333. PubMed ID: 34688698
[TBL] [Abstract][Full Text] [Related]
3. Atropine in ameliorating the progression of myopia in children with mild to moderate myopia: a meta-analysis of controlled clinical trials.
Song YY; Wang H; Wang BS; Qi H; Rong ZX; Chen HZ
J Ocul Pharmacol Ther; 2011 Aug; 27(4):361-8. PubMed ID: 21649523
[TBL] [Abstract][Full Text] [Related]
4. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
5. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
Huang J; Wen D; Wang Q; McAlinden C; Flitcroft I; Chen H; Saw SM; Chen H; Bao F; Zhao Y; Hu L; Li X; Gao R; Lu W; Du Y; Jinag Z; Yu A; Lian H; Jiang Q; Yu Y; Qu J
Ophthalmology; 2016 Apr; 123(4):697-708. PubMed ID: 26826749
[TBL] [Abstract][Full Text] [Related]
6. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
7. Reducing the progression of myopia with atropine: a long term cohort study of Olmsted County students.
Kennedy RH; Dyer JA; Kennedy MA; Parulkar S; Kurland LT; Herman DC; McIntire D; Jacobs D; Luepker RV
Binocul Vis Strabismus Q; 2000; 15(3 Suppl):281-304. PubMed ID: 11486796
[TBL] [Abstract][Full Text] [Related]
8. Atropine slows myopia progression more in Asian than white children by meta-analysis.
Li SM; Wu SS; Kang MT; Liu Y; Jia SM; Li SY; Zhan SY; Liu LR; Li H; Chen W; Yang Z; Sun YY; Wang N; Millodot M
Optom Vis Sci; 2014 Mar; 91(3):342-50. PubMed ID: 24445721
[TBL] [Abstract][Full Text] [Related]
9. Prevention of myopia onset with 0.025% atropine in premyopic children.
Fang PC; Chung MY; Yu HJ; Wu PC
J Ocul Pharmacol Ther; 2010 Aug; 26(4):341-5. PubMed ID: 20698798
[TBL] [Abstract][Full Text] [Related]
10. Topical atropine in retarding myopic progression and axial length growth in children with moderate to severe myopia: a pilot study.
Fan DS; Lam DS; Chan CK; Fan AH; Cheung EY; Rao SK
Jpn J Ophthalmol; 2007; 51(1):27-33. PubMed ID: 17295137
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.
Repka MX; Weise KK; Chandler DL; Wu R; Melia BM; Manny RE; Kehler LAF; Jordan CO; Raghuram A; Summers AI; Lee KA; Petersen DB; Erzurum SA; Pang Y; Lenhart PD; Ticho BH; Beck RW; Kraker RT; Holmes JM; Cotter SA;
JAMA Ophthalmol; 2023 Aug; 141(8):756-765. PubMed ID: 37440213
[TBL] [Abstract][Full Text] [Related]
12. Progression of myopia.
Kennedy RH
Trans Am Ophthalmol Soc; 1995; 93():755-800. PubMed ID: 8719698
[TBL] [Abstract][Full Text] [Related]
13. Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis.
Gan J; Li SM; Wu S; Cao K; Ma D; He X; Hua Z; Kang MT; Wei S; Bai W; Wang N
Front Med (Lausanne); 2021; 8():756398. PubMed ID: 35096861
[No Abstract] [Full Text] [Related]
14. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
Long H; Shi MH; Li X
J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
[TBL] [Abstract][Full Text] [Related]
15. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for progressive myopia in the atropine therapy for myopia study.
Loh KL; Lu Q; Tan D; Chia A
Am J Ophthalmol; 2015 May; 159(5):945-9. PubMed ID: 25640408
[TBL] [Abstract][Full Text] [Related]
17. Which low-dose atropine for myopia control?
Khanal S; Phillips JR
Clin Exp Optom; 2020 Mar; 103(2):230-232. PubMed ID: 31489714
[No Abstract] [Full Text] [Related]
18. Atropine for the treatment of childhood myopia: effect on myopia progression after cessation of atropine.
Tong L; Huang XL; Koh AL; Zhang X; Tan DT; Chua WH
Ophthalmology; 2009 Mar; 116(3):572-9. PubMed ID: 19167081
[TBL] [Abstract][Full Text] [Related]
19. Effect of Low-Concentration Atropine Eyedrops vs Placebo on Myopia Incidence in Children: The LAMP2 Randomized Clinical Trial.
Yam JC; Zhang XJ; Zhang Y; Yip BHK; Tang F; Wong ES; Bui CHT; Kam KW; Ng MPH; Ko ST; Yip WWK; Young AL; Tham CC; Chen LJ; Pang CP
JAMA; 2023 Feb; 329(6):472-481. PubMed ID: 36786791
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.
Hou P; Wu D; Nie Y; Wei H; Liu L; Yang G
Front Pharmacol; 2023; 14():1227787. PubMed ID: 37767401
[No Abstract] [Full Text] [Related]
[Next] [New Search]
